Papillary Thyroid Carcinoma Laparoscopy
Showing 51 - 75 of >10,000
Papillary Thyroid Carcinoma Trial in Zagazig (Total thyroidectomy and central neck dissection)
Unknown status
- Papillary Thyroid Carcinoma
- Total thyroidectomy and central neck dissection
-
Zagazig, EgyptZagazig University Hospitals
Apr 2, 2020
Thyroid Tumors Trial in Lexington (Lenalidomide)
Completed
- Thyroid Neoplasms
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
May 28, 2020
Postoperative Re-stratification for Recurrence in
Completed
- Well Differentiated Thyroid Carcinoma
- Papillary Thyroid Cancer
- UNILATERAL THYROIDECTOMY
- (no location specified)
Aug 4, 2020
Papillary Thyroid Cancer Trial in Baltimore (Radiofrequency Ablation)
Active, not recruiting
- Papillary Thyroid Cancer
- Radiofrequency Ablation
-
Baltimore, MarylandJohns Hopkins Hospital
Dec 5, 2022
Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer Trial run by the NCI (Total Thyroidectomy (TT),
Terminated
- Low-risk Papillary Thyroid Cancer
- +2 more
- Total Thyroidectomy (TT)
- Prophylactic central neck lymph node dissection (pCND)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 8, 2022
Thyroid Cancer Trial in Shanghai (Lateral neck sentinel lymph node biopsy, Modified lateral neck lymph node dissection, Super
Recruiting
- Thyroid Cancer
- Lateral neck sentinel lymph node biopsy
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 16, 2020
Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Recruiting
- Thyroid Cancer
- NTRK fusion assessment
-
Roma, ItalyRegina Elena National Cancer Institute
Mar 31, 2023
Thyroid Nodule Trial (thyroidectomy)
Not yet recruiting
- Thyroid Nodule
- thyroidectomy
- (no location specified)
Dec 17, 2022
Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)
Recruiting
- Thyroid Cancer
- Recurrence
- prophylactic central neck dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
-
La Jolla, California
- +58 more
Jan 13, 2023
Human Thyroid and Iodine Resistance
Recruiting
- Thyroid Cancer
- Metabolites dosage
-
Toulouse, FranceInstitut Claudius regaud IUCT Oncopole
Dec 22, 2022
Selenium Deficiency, Thyroid Cancer TNM Staging, Recurrence Trial in Jinan (Selenium Yeast, Placebo)
Not yet recruiting
- Selenium Deficiency
- +3 more
- Selenium Yeast
- Placebo
-
Jinan, Shandong, ChinaThe First affiliated hospital of Shandong First Medical Universi
Mar 11, 2022
A Taiwanese Oncogenetic Panel and Integrated Clinical Data
Recruiting
- Thyroid Cancer
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
-
Kaohsiung, Taiwan
- +7 more
Sep 12, 2022
Papillary Thyroid Cancer Trial in Guangzhou (GTPET(Gasless Transaxillary Posterial Endoscopic Thyroidectomy), COT(Conventional
Recruiting
- Papillary Thyroid Cancer
- GTPET(Gasless Transaxillary Posterial Endoscopic Thyroidectomy)
- COT(Conventional Open Thyroidectomy)
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Sep 15, 2022
Thyroid Carcinoma
Recruiting
- Differentiated Thyroid Carcinoma
- Medullary Thyroid Carcinoma
- Immunohistochemistry (IHC)
- +2 more
-
L'Hospitalet De Llobregat, Barcelona, Spain
- +11 more
Mar 22, 2022
Familial Non-medullary Thyroid Cancer
Recruiting
- Non-Medullary Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)
Not yet recruiting
- Thyroid Cancer
- 20 mg Famitinib & 1200 mg Adebrelimab
- (no location specified)
Nov 26, 2023
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Thyroglobulin Point of Care Assay for Rapid Detection of
Recruiting
- Differentiated Thyroid Cancer
- Lymph Node Metastases
- Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
-
Ashkelon, Israel
- +2 more
Oct 25, 2022
Thyroid Cancer Trial in Hangzhou (Resection based on "thymus-vascular-inferior parathyroid" complex)
Not yet recruiting
- Thyroid Cancer
- Resection based on "thymus-vascular-inferior parathyroid" complex
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital Zhejiang University School of Medicin
Feb 24, 2023
Association Between Primary Aldosteronism and Thyroid Cancer
Completed
- Thyroid Cancer, Papillary
- Primary Aldosteronism
- Secreening test for primary aldosteronism and Confirmatory Testing
-
São Paulo, BrazilAna Alice Wolf Maciel
Oct 3, 2023
Assessment of CA 19-9 in Patients' With Thyroid Malignancies
Not yet recruiting
- Thyroid Cancer
- Laboratory investigations for control: a-Complete blood count. b-Liver function test. c-kidney function test. d-thyroid-stimulating hormone,T3 and T4. e-Assessment of levels of CA19-9.
-
Sohag, EgyptSohag faculty of medicine
Nov 6, 2021
Papillary Thyroid Cancer and Central Lymp Node Dissection
Completed
- Papillary Thyroid Cancer
-
Istanbul, TurkeyBasaksehirCamSakuraSehirH
May 15, 2023